{
  "symbol": "BIAFW",
  "company_name": "Bioaffinity Technologies WT",
  "ir_website": "https://ir.bioaffinitytech.com/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "bioAffinity Announces a Transformative Partnership Agreement",
          "url": "https://ir.bioaffinitytech.com/news-events/press-releases/bioaffinity-announces-a-transformative-partnership-agreement",
          "content": "**Your web browser (Chrome 91) has a serious security vulnerability!** Update your browser for more security, speed and the best experience on this site. [Update browser](https://browser-update.org/update-browser.html#3.3.55:ir.bioaffinitytech.com) Ignore\n\n[ ![bioAffinity](https://d1io3yog0oux5.cloudfront.net/_af007dbea7326a0f774b94ca85c43817/bioaffinitytech/files/theme/site-files/20221031/bioaffinitytech.com/wp-content/uploads/2022/08/bioAfinity_logo.png) ](https://www.bioaffinitytech.com/)\n\nSelect Page\n\n  * [Home](https://www.bioaffinitytech.com/)\n  * [Publications](https://www.bioaffinitytech.com/scientific-publications/)\n  * [News](https://www.bioaffinitytech.com/articles-and-events/)\n  * [About](https://www.bioaffinitytech.com/about/)\n  * [Contact](https://www.bioaffinitytech.com/contact/)\n  * [Investor Relations](/)\n\n\n\n# Page Not Found\n\n  * [Email Alerts](/news-events/email-alerts)\n  * [Contacts](/company-information/contacts)\n  * [RSS News Feed](https://ir.bioaffinitytech.com/news-events/press-releases/rss \"Opens in a new window\")\n\n\n\n[  ](tel:\\(210\\)%20698-5334 \"Opens in a new window\")\n\n####  [Phone](tel:\\(210\\)%20698-5334 \"Opens in a new window\")\n\n[(210) 698-5334](tel:\\(210\\)%20698-5334)\n\n\n\n####  Email\n\ninfo@bioaffinitytech.com\n\n[  ](https://www.linkedin.com/company/bioaffinitytechnologies/ \"Opens in a new window\")\n\n####  [LinkedIn](https://www.linkedin.com/company/bioaffinitytechnologies/ \"Opens in a new window\")\n\n[…/bioaffinitytechnologies](https://www.linkedin.com/company/bioaffinitytechnologies \"Opens in a new window\")\n\n[  ](https://twitter.com/bioAffinity \"Opens in a new window\")\n\n####  [Twitter](https://twitter.com/bioAffinity \"Opens in a new window\")\n\n[@bioAffinity](https://twitter.com/bioAffinity \"Opens in a new window\")\n\n##  Subscribe for News from bioAffinity Technologies \n\n[ Subscribe ](/news-events/email-alerts)\n"
        },
        {
          "title": "bioAffinity Technologies Reports Third Quarter 2024 Financial Results",
          "url": "https://ir.bioaffinitytech.com/news-events/press-releases/bioaffinity-technologies-reports-q3-2024-financial-results",
          "content": "[ ![bioAffinity](https://d1io3yog0oux5.cloudfront.net/_af007dbea7326a0f774b94ca85c43817/bioaffinitytech/files/theme/site-files/20221031/bioaffinitytech.com/wp-content/uploads/2022/08/bioAfinity_logo.png) ](https://www.bioaffinitytech.com/)\n\nSelect Page\n\n  * [Home](https://www.bioaffinitytech.com/)\n  * [Publications](https://www.bioaffinitytech.com/scientific-publications/)\n  * [News](https://www.bioaffinitytech.com/articles-and-events/)\n  * [About](https://www.bioaffinitytech.com/about/)\n  * [Contact](https://www.bioaffinitytech.com/contact/)\n  * [Investor Relations](/)\n\n\n\n# Page Not Found\n\n  * [Email Alerts](/news-events/email-alerts)\n  * [Contacts](/company-information/contacts)\n  * [RSS News Feed](https://ir.bioaffinitytech.com/news-events/press-releases/rss \"Opens in a new window\")\n\n\n\n[  ](tel:\\(210\\)%20698-5334 \"Opens in a new window\")\n\n####  [Phone](tel:\\(210\\)%20698-5334 \"Opens in a new window\")\n\n[(210) 698-5334](tel:\\(210\\)%20698-5334)\n\n\n\n####  Email\n\ninfo@bioaffinitytech.com\n\n[  ](https://www.linkedin.com/company/bioaffinitytechnologies/ \"Opens in a new window\")\n\n####  [LinkedIn](https://www.linkedin.com/company/bioaffinitytechnologies/ \"Opens in a new window\")\n\n[…/bioaffinitytechnologies](https://www.linkedin.com/company/bioaffinitytechnologies \"Opens in a new window\")\n\n[  ](https://twitter.com/bioAffinity \"Opens in a new window\")\n\n####  [Twitter](https://twitter.com/bioAffinity \"Opens in a new window\")\n\n[@bioAffinity](https://twitter.com/bioAffinity \"Opens in a new window\")\n\n##  Subscribe for News from bioAffinity Technologies \n\n[ Subscribe ](/news-events/email-alerts)\n"
        }
      ]
    }
  ]
}